GLP-1 Users Four Times More Likely to Experience Nail Detachment, Study Finds
A new study found that nail detachment is more than four times more common among GLP-1 medication users than nonusers, with 46 percent of users reporting nail discoloration. Researchers say the finding adds to a growing list of side effects being tracked as GLP-1 drugs become widely used for weight loss and diabetes management.
Nail detachment is more than four times more common among people taking GLP-1 medications than among those who do not use the drugs, according to a new study published in October 2026. The research also found that 46 percent of GLP-1 users reported nail discoloration.
GLP-1 receptor agonists, which include drugs like Ozempic, Wegovy, and Mounjaro, have become widely prescribed for weight loss and type 2 diabetes management. As their use has expanded, researchers have been tracking a broader range of side effects beyond the well-known gastrointestinal symptoms like nausea and vomiting.
The nail findings are among the more unexpected side effects to emerge from real-world use data. Researchers say the mechanism is not yet fully understood, but some hypothesize that rapid weight loss and changes in nutrient absorption may affect nail health.
The study adds to a growing body of research examining GLP-1 side effects in large patient populations. Other recent findings have looked at the drugs' effects on muscle mass, bone density, and mental health.
Doctors advise patients taking GLP-1 medications to report any unusual physical changes to their healthcare providers. The nail detachment finding does not change current prescribing guidelines, but researchers say it warrants further study to understand how common the problem is and whether it resolves after stopping the medication.
